← All diseases Cancer

Uterine cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (129)Meta-analysis (53)Treatment guideline (2)Systematic review (40)Randomized trial (25)Phase 3 study (9)Clinical trial (626)Review article (292)Early study (phase 1 or 2) (28)Single patient description (130)Laboratory or animal study (40)Commentary or editorial (30)Retracted publication (6) Studies currently seeking participants only (40)

Filter

Publications and studies (2288)

• Building a foundation to promote Women's health research in Dubai. Study protocol for a project to investigate the feasibility of establishing a dedicated Women's health biobank. (2026/02/12) ♡
• Risk stratification for endometrial cancer: independent and joint effects of polygenic risk score and body mass index in 129,829 UK Biobank participants. (2026/02/10) ♡
• Leisure-Time Physical Activity and Cancer Mortality Among Cancer Survivors. (2026/02/02) ♡
• Patient-reported outcomes and experiences following robotic, laparoscopic, and open surgery for endometrial cancer. (2026/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Complications and recurrence after pelvic exenteration for gynecologic malignancies: Analysis of surgical complications from the COREPEX study. (2026/02/01) ♡
• Access to molecular classification in endometrial cancer recommended by ESGO-ESTRO-ESP guidelines: multi-national survey in Eastern Europe. (2026/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The POLE paradox in advanced endometrial cancer: can biology replace oncologic evidence? (2026/02/01) ♡
• European Society for Medical Oncology 2025 Highlights: Top Studies In Gynecologic Oncology. (2026/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Electronic nose-based volatile organic compound profiling in gynecologic oncology: current evidence and diagnostic accuracy. (2026/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Application of hysteroscopic morphology in endometrial cancer diagnosis and fertility preservation: scientific insights and clinical artistry. (2026/02/01) ♡
• Association of preoperative G8 score with survival, preoperative anemia and vitamin D status in gynecologic cancer patients: 5-year analysis of the Frail-B study. (2026/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies. (2026/02/01) ♡
• Moutan cortex ameliorates perimenopausal syndrome by regulating the KISS1R-ERK1/2-GnRH signaling pathway: Evidence from serum pharmacochemistry and network pharmacology. (2026/01/30) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy: Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC). (2026/01/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Collision tumor of endometrial hepatoid adenocarcinoma and endometrial stromal sarcoma: a rare case and literature review. (2026/01/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody-drug conjugates, and clinical trial innovations. (2026/01/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress on discharge readiness service practices for patients undergoing endometrial cancer surgery. (2026/01/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic potential of epigallocatechin gallate in gynecologic cancer, endometriosis, polycystic ovary syndrome: a mechanistic and translational perspective. (2026/01/13) ♡
• Development of a machine learning model for predicting the expression of proteins associated with targeted therapy in endometrial cancer. (2026/01/12) ♡
• Single-port robotic-assisted wet colostomy after total pelvic exenteration: a feasibility video report. (2026/01/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The molecular classification ushers in a new era for the treatment of advanced and recurrent endometrial cancer. (2026/01/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of circulating tumor DNA in gynecological cancer management. (2026/01/12) ♡
• Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology. (2026/01/12) ♡
• Vaginal lavage fluid can serve as a reliable method for early screening of endometrial cancer: a proof-of-concept study. (2026/01/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Immune-Mediated Diabetes Induced by Dostarlimab: A Case Report. (2026/01/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy in endometrial cancer: mechanisms, clinical evidence, and future directions. (2026/01/09) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of PARP inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis. (2026/01/07) ♡
• Higher consumption of sugar-sweetened beverages is associated with an increased risk of endometrial cancer: a prospective cohort study of 92,777 women from the UK Biobank. (2026/01/07) ♡
• Human epidermal growth factor receptor 2 expression in gynecologic serous carcinomas and preliminary analysis of its characteristics in patients post-neoadjuvant chemotherapy. (2026/01/06) ♡
• Genome-wide CRISPR screen identified NEK6 as a determinant of sensitivity to CDK4/6 inhibitor in endometrial cancer. (2026/01/05) ♡
• Artificial intelligence-based magnetic resonance imaging for preoperative staging of patients with endometrial cancer: a systematic review and meta-analysis. (2026/01/05) ♡
• Fertility preservation in gynecologic oncology: evaluating knowledge, practices, and barriers among French healthcare providers. (2026/01/01) ♡
• Waist-to-hip ratio measured with computed tomography as a predictor of surgical outcomes in minimally invasive procedures for early-stage endometrial cancer. (2026/01/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer: 1-Year follow-up after final analysis of the ENGOT-en9/LEAP-001 phase 3 trial. (2026/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE). (2026/01/01) ♡
• The Effect of Melatonin on Endometrial Histology in Patients with Endometrial Proliferative Disorders: A Double-Blind Randomized Clinical Trial. (2026/01/01) ♡
• Exploring Microsatellite Instability in Endometrial Carcinomas: Clinicopathological Correlations and Clinical Implications-A Study from North India. (2026/01/01) ♡
• Comparative Study of Minimally Invasive with Open Surgical Staging Procedure for Endometrial Cancer: A Single-Institution Experience. (2026/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Value of diffusion-weighted imaging in endometrial carcinoma staging and myometrial mesenchymal tumour characterisation. (2026/01/01) ♡
• Life's Essential 8 and the Risk of Overall and Specific-Site Cancer Types: A Large-Scale Prospective Cohort Study. (2026/01/01) ♡
• Healthcare provider bias in cancer treatment decisions for elderly patients. (2026/01/01) ♡
• Healthy Eating Index-2020 and Risk of Endometrial Cancer: A Case-Control Study Among Iranian Women. (2026/01/01) ♡
• Association of sleep quality and urinary melatonin levels with endometrial cancer: A case control pilot study. (2026/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Extrapulmonary lymphangioleiomyomatosis with retroperitoneal lymph node involvement]. (2026/01/01) ♡
• Curcumae Rhizoma and Sparganii Rhizoma component compatibility exerts an inhibitory effect on endometrial cancer by regulating HDAC8/PTEN/Akt axis. (2026/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer (2026-08-10) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. (2026-08-10) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors (2026-08-10) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (2026-08-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation (2026-08-10) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.